Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02111057 · ClinicalTrials.gov registry record

Perioperative Flare in RA: Characterization of Clinical and Biological Features

A clinical trial of Rheumatoid Arthritis, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
162
Enrollment target
1
Study location

NCT02111057 is a study of Rheumatoid Arthritis that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 162 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02111057, a study of Rheumatoid Arthritis, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
162 participants
Enrollment target
1
Study location

Study Summary

Researchers at the Hospital for Special Surgery are trying to learn more about post-operative rheumatoid arthritis flare (RA). This study hopes to understand RA flare after total joint replacement surgery and what the result of flaring is for patients over the 6 weeks post operation. Through this study we aim to describe rates, characteristics, and risk factors of RA flare within 6 weeks of total hip arthroplasty (THA) and total knee arthroplasty (TKA)

Conditions Studied

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2013-10-16
Est. Completion 2017-05-09

What the Registry Record Tells You About NCT02111057

The ClinicalTrials.gov registry entry for NCT02111057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT02111057 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02111057 about?

NCT02111057 is a clinical study titled "Perioperative Flare in RA: Characterization of Clinical and Biological Features". Researchers at the Hospital for Special Surgery are trying to learn more about post-operative rheumatoid arthritis flare (RA). This study hopes to understand RA flare after total joint replacement surgery and what the result of flaring is for patients over the 6 weeks post operation. Through this s...

What is the current status of trial NCT02111057?

This trial is currently completed. The enrollment target is 162 participants. The study started on 2013-10-16. Estimated completion is 2017-05-09.

What conditions does trial NCT02111057 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

Who is sponsoring clinical trial NCT02111057?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02111057 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.